Wilson PM - Search Results

1

The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.

Allen WL, McLean EG, Boyer J, McCulla A, Wilson PM, Coyle V, Longley DB, Casero RA Jr, Johnston PG. Allen WL, et al. Among authors: wilson pm. Mol Cancer Ther. 2007 Jan;6(1):128-37. doi: 10.1158/1535-7163.MCT-06-0303. Mol Cancer Ther. 2007. PMID: 17237273

2

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG. Boyer J, et al. Among authors: wilson pm. Cancer Res. 2006 Mar 1;66(5):2765-77. doi: 10.1158/0008-5472.CAN-05-2693. Cancer Res. 2006. PMID: 16510598

3

Novel opportunities for thymidylate metabolism as a therapeutic target.

Wilson PM, Fazzone W, LaBonte MJ, Deng J, Neamati N, Ladner RD. Wilson PM, et al. Mol Cancer Ther. 2008 Sep;7(9):3029-37. doi: 10.1158/1535-7163.MCT-08-0280. Mol Cancer Ther. 2008. PMID: 18790783 Free PMC article.

4

Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway.

Stevenson L, Allen WL, Proutski I, Stewart G, Johnston L, McCloskey K, Wilson PM, Longley DB, Johnston PG. Stevenson L, et al. Among authors: wilson pm. PLoS One. 2011;6(5):e20276. doi: 10.1371/journal.pone.0020276. Epub 2011 May 24. PLoS One. 2011. PMID: 21629658 Free PMC article.

5

Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer.

Wilson PM, LaBonte MJ, Lenz HJ, Mack PC, Ladner RD. Wilson PM, et al. Mol Cancer Ther. 2012 Mar;11(3):616-28. doi: 10.1158/1535-7163.MCT-11-0781. Epub 2011 Dec 15. Mol Cancer Ther. 2012. PMID: 22172489

6

Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.

Wilson PM, Danenberg PV, Johnston PG, Lenz HJ, Ladner RD. Wilson PM, et al. Nat Rev Clin Oncol. 2014 May;11(5):282-98. doi: 10.1038/nrclinonc.2014.51. Epub 2014 Apr 15. Nat Rev Clin Oncol. 2014. PMID: 24732946 Review.

7

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells.

Fazzone W, Wilson PM, Labonte MJ, Lenz HJ, Ladner RD. Fazzone W, et al. Among authors: wilson pm. Int J Cancer. 2009 Jul 15;125(2):463-73. doi: 10.1002/ijc.24403. Int J Cancer. 2009. PMID: 19384949

8

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.

LaBonte MJ, Yang D, Zhang W, Wilson PM, Nagarwala YM, Koch KM, Briner C, Kaneko T, Rha SY, Gladkov O, Urba SG, Sakaeva D, Pishvaian MJ, Hsieh RK, Lee WP, Lenz HJ. LaBonte MJ, et al. Among authors: wilson pm. Mol Cancer Ther. 2016 Sep;15(9):2251-8. doi: 10.1158/1535-7163.MCT-15-0908. Epub 2016 Jun 20. Mol Cancer Ther. 2016. PMID: 27325685 Free PMC article. Clinical Trial.

9

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

LaBonte MJ, Manegold PC, Wilson PM, Fazzone W, Louie SG, Lenz HJ, Ladner RD. LaBonte MJ, et al. Among authors: wilson pm. Int J Cancer. 2009 Dec 15;125(12):2957-69. doi: 10.1002/ijc.24658. Int J Cancer. 2009. PMID: 19536776

10

Molecular markers in the treatment of metastatic colorectal cancer.

Wilson PM, Labonte MJ, Lenz HJ. Wilson PM, et al. Cancer J. 2010 May-Jun;16(3):262-72. doi: 10.1097/PPO.0b013e3181e07738. Cancer J. 2010. PMID: 20526105 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters